Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Transaction in Own Shares and Total Voting Rights

20 Sep 2018 17:37



Transaction in Own Shares and Total Voting Rights



Transaction in Own Shares and Total Voting Rights


Octopus AIM VCT 2 plc (“the Company”)

20 September 2018

Amendment: Purchase of own securities and total voting rights

Amendment of RNS published at 14:34 on 20 September 2018 - The original announcement had the incorrect heading Net Asset Value(s) and this has been amended to reference the correct heading Transaction in Own Shares and Total Voting Rights.

Octopus AIM VCT 2 plc announces that on 20 September 2018 the Company purchased for cancellation 360,001 Ordinary shares at a price of 90p per share.

Following this transaction, the issued share capital of the Company now consists of 98,665,387 Ordinary shares with a nominal value of 0.01p each, with voting rights.

For further enquiries, please contact:

Suzanna Waterhouse,Company Secretary

020 3142 4957




© 2018 GlobeNewswire, Inc. All rights reserved.




Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.